Key facts
- It has raised $14.0M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, Shenzhen Guozhong Venture Capital Management, Leader Venture Capital, Suzhou Zhongxin Innovation Investment Management, CDBI Partners — 11 tracked in total.
- Status: Privately Held (backing).
Investors
11+- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Senas Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Senas Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Senas Medical Technology
Developer of cardiac electrophysiology medical devices designed to enable minimally invasive treatment of cardiovascular conditions. The company offers radiofrequency ablation systems, integrated pacing and saline-based ablation technology, and precision-guided interventional techniques, enabling clinicians and healthcare providers to perform safer procedures and improve patient treatment outcomes.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Employees
- 2
- Ownership
- Privately Held (backing)
Senas Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Senas Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Senas Medical Technology in its N-PORT filings yet. We sweep new filings monthly.